Press release
Cancer Biomarkers Market to Reach USD 79.4 Billion by 2035, Growth Accelerates Across Europe, North America, USA, and UK
Technological progress in genomics, proteomics, and liquid biopsy is reshaping how cancers are diagnosed, monitored, and treated. With healthcare systems focusing more on personalised medicine and risk stratification, biomarker testing is becoming a cornerstone of modern oncology.
➤Key Market Insights at a Glance
Market Size 2025: USD 14.2 billion
Forecast 2035: USD 48.44 billion
CAGR (2025-2035): ~13%
Leading Test Types: PSA, CA, and HER2 biomarker tests
Top Cancer Applications: Breast, prostate, lung
Fastest-Rising Technology: Liquid biopsy & multi-omics platforms
Market Leaders: North America with rapid expansion in Asia Pacific
To Access the Complete Data Tables & in-depth Insights, Request a Discount on this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4587
➤Market Drivers / Growth Overview
A growing emphasis on early-stage cancer detection, coupled with advances in molecular diagnostics, is accelerating biomarker utilisation. Integration of AI and next-generation sequencing (NGS) in oncology research improves diagnostic precision and turnaround times.
Liquid biopsy technologies enabling non-invasive detection through blood analysis are gaining widespread clinical support. Rising investment in biomarker-driven drug discovery and companion diagnostics continues to strengthen commercial pipelines across pharmaceutical and biotech companies.
Government initiatives promoting cancer screening and value-based care models further enhance long-term adoption.
➤Key Growth Drivers at a Glance
Rising Global Cancer Cases driving screening and early detection
Precision Medicine Expansion through targeted therapy alignment
NGS & Liquid Biopsy Adoption boosting diagnostic capability
AI + Data Analytics accelerating biomarker validation
Pharma-Diagnostic Partnerships for co-developed therapeutics
Supportive Reimbursement Policies improving accessibility
Emerging Economies Uptake expanding patient coverage
➤Segmentation & Key Drivers
By Test Type:
PSA, CTC, HER2, CA, AFP, KRAS, ALK, BRCA, and other tumour-specific genetic markers. PSA and CA tests remain dominant, while NGS-driven gene panels grow fastest.
By Cancer Indication:
Breast cancer leads volumes followed by prostate, lung, and colorectal cancers, supported by screening guidelines and therapy monitoring needs.
By Technology:
Liquid biopsy and multi-omics deliver improved specificity and early detection capabilities versus conventional diagnostics.
➤Regional & Country Insights (Bullet Format)
North America:
Strong R&D ecosystem and rapid adoption of advanced screening tools
Europe:
Government-endorsed cancer awareness and early detection programs
Asia Pacific:
Highest growth rate fueled by increasing cancer cases and diagnostics expansion in China and India
Latin America:
Growing access to molecular tests through healthcare investments
Middle East & Africa:
Gradual biomarker adoption supported by improving oncology infrastructure
➤Five Forces Driving Market Growth
Innovation Velocity in genomics and AI-supported testing
Demand Surge for personalised therapy decisions
Competitive Intensification encouraging rapid product evolution
Complementary Use alongside traditional diagnostic pathways
Policy Support through enhanced reimbursement and awareness
➤Competitive Landscape
The competitive environment is moderately consolidated with major leaders and niche innovators expanding assay portfolios and oncology partnerships.
Key companies include:
Abbott Laboratories • F. Hoffmann-La Roche Ltd. • Thermo Fisher Scientific Inc. • QIAGEN N.V. • Illumina Inc. • Agilent Technologies Inc. • Bio-Rad Laboratories Inc. • PerkinElmer Inc. • Myriad Genetics Inc. • Sysmex Corporation • Siemens Healthineers AG • Hologic Inc. • Biocept Inc.
Industry participants focus on high-sensitivity assays, automation improvements, AI-enabled workflows, and integrated multi-omic platforms.
➤Recent Developments
Roche expanded biomarker-based companion diagnostics across oncology therapeutics
Abbott released upgraded immunoassays improving cancer marker reliability
Illumina launched multi-cancer NGS liquid biopsy panels for early detection
QIAGEN partnered with pharma companies to advance immuno-oncology CDx
Thermo Fisher Scientific upgraded its Oncomine line for precision medicine integration
Agilent Technologies expanded its proteogenomic biomarker discovery services
Bio-Rad and PerkinElmer advanced automated clinical lab workflows
Advancements underline the market's pivot toward minimally invasive, precision-led diagnostics.
➤Market Outlook & Strategic Insights
The forecasted period will see cancer biomarkers transition from optional to mainstream diagnostic tools, underpinning early detection and personalised treatment pathways. Companies that:
Accelerate liquid biopsy adoption
Integrate AI-enabled analytics
Expand multi-omics coverage
Develop cost-effective screening tests
will secure future market leadership.
The cancer biomarkers market is set to play a transformative role in improving survival outcomes worldwide.
Browse Full Report: https://www.factmr.com/report/4587/cancer-biomarkers-market
➤Purchase Full Report for Detailed Insights
For access to full forecasts, regional breakouts, company share analysis, and emerging trend assessments, you can purchase the complete report: https://www.factmr.com/checkout/4587
Have specific requirements or need assistance on report pricing or have a limited budget? Please contact sales@factmr.com
➤Related Reports:
Cancer Therapeutics Market: https://www.factmr.com/report/4296/cancer-therapeutics-market
Cancer Genomic Testing Market: https://www.factmr.com/report/3999/cancer-genomic-testing-market
Cancer Supportive Care Product Market: https://www.factmr.com/report/cancer-supportive-care-product-market
Cancer Immunotherapy Market: https://www.factmr.com/report/4367/cancer-immunotherapy-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
➤About Fact.MR:
Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market to Reach USD 79.4 Billion by 2035, Growth Accelerates Across Europe, North America, USA, and UK here
News-ID: 4259259 • Views: …
More Releases from Fact.MR
Non-Alcoholic Wine Market to Reach USD 7.64 Billion by 2035, Growing at a CAGR o …
The global non-alcoholic wine market is projected to rise from USD 2.84 billion in 2025 to approximately USD 7.64 billion by 2035, expanding at a robust compound annual growth rate (CAGR) of about 10.4%. Growth is underpinned by accelerating consumer interest in mindful drinking, health-centric consumption, and premium alcohol-free alternatives that mirror the taste and sophistication of traditional wines.
Technological advances in dealcoholisation, growing availability through retail and online channels, and…
Global Floor Grinder Rental Market to Hit USD 1.08 Billion by 2035 - Double Head …
The global floor grinder rental market is poised for steady expansion, projected to grow from USD 760.0 million in 2025 to USD 1,080.0 million by 2035, representing a CAGR of 3.5%, according to Fact.MR. Rising demand for professional surface preparation services, cost-effective equipment rentals, and efficient floor treatment solutions is fueling growth across construction and industrial sectors.
Double Head and Concrete Polishing Lead Market Adoption
Double head grinders dominate the market with…
Global Forklift Rental Market to Reach USD 25 Billion by 2035 - Electric and Cou …
The global forklift rental market is on a steady growth trajectory, projected to expand from USD 17.4 billion in 2025 to USD 25.0 billion by 2035, registering a CAGR of 3.7%, according to Fact.MR's latest market analysis. The surge reflects growing adoption of flexible material handling solutions, cost-effective equipment management strategies, and rising industrial and warehousing demands worldwide.
Electric Forklifts Lead the Charge
Electric forklifts are expected to dominate the rental landscape,…
Global Farm Equipment Rental Market Forecast 2025-2035: APAC Dominates with 7.5% …
The global farm equipment rental market is poised for remarkable growth over the next decade, fueled by increasing mechanization, rising operational costs, and a shift toward cost-effective, sustainable farming practices. According to Future Market Insights (FMI), the market is experiencing a surge in demand as small- and medium-sized farms increasingly prefer rental models over outright equipment ownership.
The FMI report, "Farm Equipment Rental Market Size, Share, and Forecast 2025-2035," highlights that…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
